Largest biotech companies by market cap: 55 companies with a combined market value of $745.54 B. Amgen Inc. (AMGN) leads at $182.28 B. Biological product and biotechnology research companies ranked by market value. Rankings update as fresh market data lands; click any company for its financial statements, charts, and SEC filing history.
| Rank | Company | Industry | Market Cap |
|---|---|---|---|
| 1 | Biological Products, (No Diagnostic Substances) | $182.28 B | |
| 2 | Biological Products, (No Diagnostic Substances) | $150.83 B | |
| 3 | Aargenx SEARGX | Biological Products, (No Diagnostic Substances) | $53.35 B |
| 4 | RRevolution Medicines, Inc.RVMD | Biological Products, (No Diagnostic Substances) | $30.65 B |
| 5 | Services-Commercial Physical & Biological Research | $30.40 B | |
| 6 | Biological Products, (No Diagnostic Substances) | $28.68 B | |
| 7 | Biological Products, (No Diagnostic Substances) | $21.79 B | |
| 8 | Services-Commercial Physical & Biological Research | $21.06 B | |
| 9 | Biological Products, (No Diagnostic Substances) | $18.25 B | |
| 10 | Biological Products, (No Diagnostic Substances) | $16.17 B | |
| 11 | Services-Commercial Physical & Biological Research | $13.30 B | |
| 12 | Biological Products, (No Diagnostic Substances) | $13.22 B | |
| 13 | IICON Public Limited CompanyICLR | Services-Commercial Physical & Biological Research | $11.04 B |
| 14 | Biological Products, (No Diagnostic Substances) | $9.21 B | |
| 15 | Services-Commercial Physical & Biological Research | $8.97 B | |
| 16 | Biological Products, (No Diagnostic Substances) | $8.36 B | |
| 17 | Biological Products, (No Diagnostic Substances) | $8.22 B | |
| 18 | Biological Products, (No Diagnostic Substances) | $8.03 B | |
| 19 | Biological Products, (No Diagnostic Substances) | $7.38 B | |
| 20 | IImmunityBio, Inc.IBRX | Biological Products, (No Diagnostic Substances) | $7.31 B |
| 21 | AArcellxACLX | Biological Products, (No Diagnostic Substances) | $6.73 B |
| 22 | PVaxcyte, Inc.PCVX | Biological Products, (No Diagnostic Substances) | $6.56 B |
| 23 | Biological Products, (No Diagnostic Substances) | $6.44 B | |
| 24 | IImmunovant, Inc.IMVT | Biological Products, (No Diagnostic Substances) | $6.40 B |
| 25 | AApogee Therapeutics, Inc.APGE | Biological Products, (No Diagnostic Substances) | $6.19 B |
| 26 | SScholar Rock Holding CorporationSRRK | Biological Products, (No Diagnostic Substances) | $5.28 B |
| 27 | CCG Oncology, Inc.CGON | Biological Products, (No Diagnostic Substances) | $4.84 B |
| 28 | Biological Products, (No Diagnostic Substances) | $4.77 B | |
| 29 | Biological Products, (No Diagnostic Substances) | $4.22 B | |
| 30 | DDenali Therapeutics Inc.DNLI | Biological Products, (No Diagnostic Substances) | $3.27 B |
| 31 | Biological Products, (No Diagnostic Substances) | $3.03 B | |
| 32 | Biological Products, (No Diagnostic Substances) | $2.73 B | |
| 33 | TTarsus Pharmaceuticals, Inc.TARS | Biological Products, (No Diagnostic Substances) | $2.64 B |
| 34 | Biological Products, (No Diagnostic Substances) | $2.58 B | |
| 35 | Biological Products, (No Diagnostic Substances) | $2.08 B | |
| 36 | Biological Products, (No Diagnostic Substances) | $1.99 B | |
| 37 | KKodiak Sciences Inc.KOD | Biological Products, (No Diagnostic Substances) | $1.97 B |
| 38 | AADMA Biologics, Inc.ADMA | Biological Products, (No Diagnostic Substances) | $1.97 B |
| 39 | Biological Products, (No Diagnostic Substances) | $1.91 B | |
| 40 | Biological Products, (No Diagnostic Substances) | $1.69 B | |
| 41 | Biological Products, (No Diagnostic Substances) | $1.62 B | |
| 42 | Biological Products, (No Diagnostic Substances) | $1.61 B | |
| 43 | TTaysha Gene Therapies, Inc.TSHA | Biological Products, (No Diagnostic Substances) | $1.55 B |
| 44 | IInhibrx Biosciences, Inc.INBX | Biological Products, (No Diagnostic Substances) | $1.53 B |
| 45 | IImmunocore Holdings plcIMCR | Biological Products, (No Diagnostic Substances) | $1.42 B |
| 46 | Biological Products, (No Diagnostic Substances) | $1.41 B | |
| 47 | Biological Products, (No Diagnostic Substances) | $1.40 B | |
| 48 | VVir Biotechnology, Inc.VIR | Biological Products, (No Diagnostic Substances) | $1.39 B |
| 49 | MMaze Therapeutics, Inc.MAZE | Biological Products, (No Diagnostic Substances) | $1.31 B |
| 50 | AAlvotechALVO | Biological Products, (No Diagnostic Substances) | $1.29 B |
| 51 | CHemab Therapeutics Holdings, Inc.COAG | Biological Products, (No Diagnostic Substances) | $1.19 B |
| 52 | Biological Products, (No Diagnostic Substances) | $1.19 B | |
| 53 | Biological Products, (No Diagnostic Substances) | $1.11 B | |
| 54 | AAbsci CorporationABSI | Services-Commercial Physical & Biological Research | $994.67 M |
| 55 | Biological Products, (No Diagnostic Substances) | $740.57 M |
Industry membership comes from each company's SEC-registered SIC classification, parsed from EDGAR submissions. Market capitalizations refresh continuously from cached market data combined with SEC-reported share counts. See the full market cap rankings or the IPO filings tracker.